A unique event in the center of Zagreb on Friday introduced a new nasal decongestant, Meralys HA, from the domestic pharmaceutical company JGL d.d. based in Rijeka. The original presentation of the new nasal spray took place in a city train that moved through the city center with media representatives and consumers. The new Meralys HA thus introduced the public in an interesting way to its properties and mode of action, as well as all relevant information related to its innovative “3-in-1” concept. This was an introduction to a series of consumer activities organized this Saturday at the City Center one West in Zagreb, which will continue on Saturday, November 21, 2015.
“As a leading company in innovative products for nasal health and care, we are extremely pleased to present Meralys HA to the market, yet another new product in the Meralys family, which we at JGL d.d. are very proud of. What makes us happiest is the fact that we have enabled consumers to have a whole range of effective products for nasal health, thus becoming dominant in addressing extremely unpleasant health issues caused by colds and respiratory diseases.“ – said Dr. Tamara Radić, Regional Director for JGL JIE, at the event.
The new Meralys HA thus introduced the public in an interesting way to its properties and mode of action, as well as all relevant information related to its innovative “3-in-1“ concept. This was an introduction to a series of activities organized for consumers at the City Center one West in Zagreb. In order to raise awareness about the importance of healthy breathing as a starting point for a healthy and functional respiratory system, consumers had the opportunity this Saturday at that Zagreb shopping center, from 9 AM to 7 PM, to participate in fun and educational activities related to Meralys HA. Along with a series of promotions for the gathered citizens, a prize game was held with valuable prizes that will surely come in handy when the cold and flu season begins.
Meralys HA* is an OTC drug that, in addition to the standard formulation (xylometazoline hydrochloride responsible for reducing nasal mucosa swelling and decongesting the nose, and seawater that thins mucus), is additionally enriched with hyaluronic acid as a natural moisturizer with a long-lasting effect. It protects and moisturizes the nasal mucosa and allows for better regeneration during frequent winter colds and flu.
